2012 - Member of Academia Europaea
His primary areas of study are Radioligand, Endocrinology, Internal medicine, Receptor and Raclopride. His studies in Radioligand integrate themes in fields like Positron emission tomography, Pharmacology, Human brain and Pathology. Christer Halldin has included themes like Ligand, Serotonin transporter, Nuclear medicine, Metabolite and Hippocampus in his Human brain study.
His Endocrinology research focuses on Neuroscience and how it connects with Radioligand Assay. The concepts of his Raclopride study are interwoven with issues in Agonist, Biophysics and Dopamine antagonist. His biological study spans a wide range of topics, including Haloperidol and Sulpiride.
His scientific interests lie mostly in Radioligand, Internal medicine, Pharmacology, Endocrinology and Receptor. His Radioligand study combines topics from a wide range of disciplines, such as Positron emission tomography, Binding potential, Nuclear medicine and Human brain. His research on Internal medicine frequently links to adjacent areas such as Neocortex.
His Pharmacology study integrates concerns from other disciplines, such as Clozapine, Antagonist and Antipsychotic. Dopamine, Raclopride, Dopamine receptor, Dopamine receptor D2 and Dopaminergic are subfields of Endocrinology in which his conducts study. Receptor is closely attributed to Neuroscience in his work.
Christer Halldin mainly focuses on Radioligand, Positron emission tomography, Pharmacology, In vivo and Internal medicine. His Radioligand study which covers Human brain that intersects with Monoamine oxidase B. His Positron emission tomography study incorporates themes from Neuroinflammation and Pathology.
In his research on the topic of Pharmacology, Glucagon is strongly related with Receptor. As part of one scientific family, he deals mainly with the area of In vivo, narrowing it down to issues related to the In vitro, and often Beta cell. His Internal medicine research incorporates themes from Endocrinology and Oncology.
Radioligand, Positron emission tomography, In vivo, Internal medicine and Pathology are his primary areas of study. His Radioligand study integrates concerns from other disciplines, such as Cerebellum, Binding potential, PDE10A, Phosphodiesterase and Human brain. The various areas that Christer Halldin examines in his In vivo study include Morphine, Pharmacology, Drug and In vitro.
His research integrates issues of Agonist, Receptor, Biomarker and Sulpiride in his study of Pharmacology. The Internal medicine study combines topics in areas such as Anesthesia, Endocrinology, Gastroenterology, Immune system and Test retest reproducibility. His biological study spans a wide range of topics, including Serotonin transporter and Serotonin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine: Relation to Extrapyramidal Side Effects
Lars Farde;Anna-Lena Nordström;Frits-Axel Wiesel;Stefan Pauli.
Archives of General Psychiatry (1992)
The gut microbiota influences blood-brain barrier permeability in mice
Viorica Braniste;Maha Al-Asmakh;Czeslawa Kowal;Farhana Anuar.
Science Translational Medicine (2014)
Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic Drugs
Lars Farde;Fritz-Axel Wiesel;Christer Halldin;Göran Sedvall.
Archives of General Psychiatry (1988)
D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
Lars Farde;Frits-Axel Wiesel;Sharon Stone-Elander;Christer Halldin.
Archives of General Psychiatry (1990)
Age-related cognitive deficits mediated by changes in the striatal dopamine system.
Lars Bäckman;Nathalie Ginovart;Roger A. Dixon;Tarja-Brita Robins Wahlin.
American Journal of Psychiatry (2000)
Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients
Anna-Lena Nordström;Lars Farde;Frits-Axel Wiesel;Kaj Forslund.
Biological Psychiatry (1993)
Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis.
L. Farde;L. Eriksson;G. Blomquist;C. Halldin.
Journal of Cerebral Blood Flow and Metabolism (1989)
Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain.
Håkan Hall;Göran Sedvall;Olle Magnusson;Jutta Kopp.
D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients.
A L Nordström;L Farde;S Nyberg;P Karlsson.
American Journal of Psychiatry (1995)
No D2 receptor increase in PET study of schizophrenia.
Lars Farde;Frits-Axel Wiesel;HÅkan Hall;Christer Halldin.
Archives of General Psychiatry (1987)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: